JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265837

人IVNS1ABP (Influenza Virus NS1A Binding蛋白) knockout HeLa cell line

Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

IVNS1ABP KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 3 and 7 bp deletion in exon 3 and Insertion of the selection cassette in exon 3. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

查看别名

Aryl hydrocarbon receptor associated 3, DKFZp686K06216, FLARA 3, HSPC068, IVNS1ABP, IVNS1ABP protein, KIAA0850, NCX downstream gene 1, ND 1, NS1 binding protein, NS1 binding protein like protein

3 Images
Sanger Sequencing - Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line (AB265837)
  • Sanger seq

Unknown

Sanger Sequencing - Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line (AB265837)

Allele-1 : Insertion of the selection cassette in exon 3.

Sanger Sequencing - Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line (AB265837)
  • Sanger seq

Unknown

Sanger Sequencing - Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line (AB265837)

Allele-3 : 1 bp deletion in exon 3.

Sanger Sequencing - Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line (AB265837)
  • Sanger seq

Unknown

Sanger Sequencing - Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line (AB265837)

Allele-2 : 7 bp deletion in exon 3.

关键信息

细胞类型

HeLa

种属

Human

组织

Cervix

形式

Liquid

form

敲除验证

Sanger Sequencing

突变描述

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 3 and 7 bp deletion in exon 3 and Insertion of the selection cassette in exon 3

疾病

Adenocarcinoma

产品详情

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

规格

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265837-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265837-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265837 Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line", "number":"AB265837-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265837-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265837 Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line", "number":"AB265837-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265837-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265837-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265837 Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line", "number":"AB265837-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265837-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265837 Human IVNS1ABP (Influenza Virus NS1A Binding Protein) knockout HeLa cell line", "number":"AB265837-CMP01", "productcode":"" } ] } } }

性能和储存信息

基因名称
IVNS1ABP
基因编辑类型
Knockout
基因编辑方法
CRISPR technology
敲除验证
Sanger Sequencing
运输条件
Dry Ice
推荐的短期储存条件
-196°C
推荐的长期储存条件
-196°C

处理步骤

初始处理指南

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

传代培养指南
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
培养基

DMEM (High Glucose) + 10% FBS

低温储藏试剂

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

Influenza Virus NS1A Binding Protein (IVNS1ABP) also known as NS1-BP is a cellular protein that interacts with the NS1 protein of the influenza virus to modulate viral replication. This interaction suppresses host antiviral responses enhancing influenza virus propagation. IVNS1ABP has a molecular weight of approximately 77 kDa. It expresses mainly in the nucleus and cytoplasm of host cells where it engages with host molecules to facilitate viral protein synthesis and assembly.
Biological function summary

IVNS1ABP contributes to the regulation of protein synthesis pathways and facilitates RNA processing by directly interacting with host machinery. It functions within a complex containing several host proteins that assist in transcriptional control and mRNA splicing. These interactions provide the influenza virus with a supportive environment for efficient propagation effectively avoiding the host's immune defenses.

Pathways

IVNS1ABP operates in the RNA processing and splicing mechanisms that are critical for both host and viral gene expression. The protein forms pathways with host RNA polymerase II and other spliceosomal components influencing the maturation of mRNA precursors. These pathways not only support viral replication but also adjust host cell pathways to prioritize viral transcription over normal cellular processes.

IVNS1ABP's modification of host defenses links it directly to influenza pathogenesis and secondary immune suppression. This protein also connects to the nonstructural NS1 protein of the influenza virus an interaction important for evading the host immune response. Understanding IVNS1ABP's role in these pathways helps develop therapeutic strategies for controlling influenza infections targeting its interactions to hinder the viral lifecycle.

质量控制

STR 分析

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

细胞培养

生物安全等级

EU: 2 US: 2

贴壁/悬浮

Adherent

性别

Female

产品实验方案

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com